Michael G. Tomasic Appointed to BioData’s Board of Directors
Tomasic contributes 30 years of leadership experience in the life science and biotech industries to BioData’s research and lab management services
BioData, the producer of
Labguru, is thrilled to announce the appointment of Michael G. Tomasic to its Board of Directors.
In a previous life, Tomasic served as President and CEO of CambridgeSoft for 20 years. Under his leadership, CambridgeSoft served over one million customers in the pharmaceutical, biotech and chemistry markets. He continued to lead the company through its 2011 acquisition by PerkinElmer, Inc., (NYSE:PKI) for over $200 million.
Tomasic is currently President of Management Technology, consulting to the software, computing, and biotech industries. He also served as Chairman of LabTech Corporation, provider of products to the chemistry market, for over 20 years.
“Labguru has established itself as a key player in the web-based research and lab management system market. Labguru’s unique value is the broad range of features it provides to individual researchers, Principal Investigators, as well as entire departments and research institutions. I’m excited to help advise and guide the company as it matures and focuses more attention on institutional clients,” said Tomasic.
BioData’s services benefit individual researchers at the bench, and also enhance collaboration and knowledge management across research teams and institutions. Labguru’s order management, equipment sharing, and storage mapping features reduce costs and streamline administrative tasks.
Timo Hannay, our Managing Director and also the Chairman of BioData’s board reports says:
“We’re honoured Michael has joined the team. His depth of knowledge and breadth of experience in the biotech and software markets are a perfect fit as we continue to establish Labguru as the leading institutional research and lab management system.”